APA (7th ed.) Citation

N, K., T, L., Z, S., PN, C., A, Y., M, S., . . . J, W. (2025). CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers. Cell chemical biology, 32(4), 556. https://doi.org/10.1016/j.chembiol.2025.03.006

Chicago Style (17th ed.) Citation

N, Kwiatkowski, et al. "CDK2 Heterobifunctional Degraders Co-degrade CDK2 and Cyclin E Resulting in Efficacy in CCNE1-amplified and Overexpressed Cancers." Cell Chemical Biology 32, no. 4 (2025): 556. https://doi.org/10.1016/j.chembiol.2025.03.006.

MLA (9th ed.) Citation

N, Kwiatkowski, et al. "CDK2 Heterobifunctional Degraders Co-degrade CDK2 and Cyclin E Resulting in Efficacy in CCNE1-amplified and Overexpressed Cancers." Cell Chemical Biology, vol. 32, no. 4, 2025, p. 556, https://doi.org/10.1016/j.chembiol.2025.03.006.